swedish drug firm astra share rose crown 690 first two hour trade stockholm bours amid hope it research into anti viral drug may have promis result treatment acquir immun defici syndrom aid stockbrok said share which climb amid heavi institut buy also rose reaction optimist assess futur product firm annual report which was releas this week broker enskilda fondkommiss said report this month astra was world leader anti viral drug although enskilda said astra had not made ani breakthrough develop specif drug treat acquir immun defici syndrom note investor were onli now discov firm approach area was promis clear astra has tradit anti viral research which should prove valuabl fight this diseas report enskilda invest bank unit skandinaviska enskilda banken said compani offici could not reach for comment caus today share rise reuter 